Diversify Advisory Services, LLC
Position in TEVA — Teva Pharmaceutical Industries Ltd
CIK 2021232
SANDY, UT
Position in TEVA
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$2,395,756
+$2,237,538 QoQ
Shares Held
70,713
+586.9% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#252
of 671 holders
Holding Since
Mar 2024
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Diversify Advisory Services, LLC holds $4,800,771 across 8 Drug Manufacturers - Specialty & Generic names. TEVA ranks #1 (49.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
This page
|
70,713 | $2,395,756 | |
| 2 | ZTS |
Zoetis Inc.
|
12,806 | $920,239 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
2,506 | $422,361 | |
| 4 | AMRX |
Amneal Pharmaceuticals, Inc.
|
17,746 | $307,183 | |
| 5 | TRLV |
Trulieve Cannabis Corp.
|
27,096 | $266,353 | |
| 6 | PBH |
Prestige Consumer Healthcare Inc.
|
5,491 | $259,559 | |
| 7 | HLN |
Haleon plc
|
22,312 | $208,170 | |
| 8 | BTAI |
BioXcel Therapeutics, Inc.
|
15,000 | $21,150 |
All Filings in TEVA
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,395,756 | 70,713 | Shares | Sole | 2026-08-10 | |
| 2025-03-31 | $158,218 | 10,294 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $448,624 | 20,355 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $357,859 | 19,859 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $165,197 | 10,166 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $143,498 | 10,170 | Shares | Sole | 2024-04-30 | |
| No filing history on record for this holder in this stock. | ||||||